RecruitingNot ApplicableNCT07251036

Serum Chordecone Concentration in Guadeloupean Population: Impact of a Multidisciplinary Support Program on the Reduction of the Contamination Level.


Sponsor

Centre Hospitalier Universitaire de la Guadeloupe

Enrollment

3,000 participants

Start Date

Jun 26, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The French West Indies (Guadeloupe, Martinique) are characterized by a major use of pesticides in bananas plantation from the 1950s. These crops used organochlorine insecticides and especially chlordecone (CLD) from 1972 to 1993. The lack of biotic and abiotic degradation of CLD led to persistent soil pollution, contamination of surface and deep waters, of numerous plant and animal, and of the population. The extent and persistence of CLD contamination over time is a major issue for these territories. An internal reference value (0.4μg/l) was recently determined. Although useful for a population approach, it must be used with caution for the interpretation of an individual result. In response to the strong social demand expressed by the population for access to free chlordecone blood tests, a screening program for blood chlordecone test was authorized by the 2019 French Finance Act.


Eligibility

Min Age: 18 Years

Inclusion Criteria3

  • All subject overs 18 years of age residing in Guadeloupe invited to participate to the program by the Regional Health Agency or subjects who requested a test from their doctor in the framework of the ministerial measure.
  • Subjects who have read the information note and signed the consent to participate in the study
  • Subjects with social security coverage

Exclusion Criteria3

  • Refusal to participate
  • Person not affiliated with a social security scheme
  • Person under legal protection (safeguard of justice, guardianship, curatorship, etc.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERCHLORGUA

The target populations will receive an invitation letter with an information notice and a consent form. The referral physician will explain the program and the research project and prescribe a standardized blood sample test. Blood samples will be taken in one of the biology laboratories participating in the project. Serum chordecone test will be performed by the Pasteur Institute of Guadeloupe. Blood samples for biological collection will be sent to the Biological Resource Center, Karubiotec™. The result of the chlordécone level will be sent back to each subject with a recommendation note based on the chlordécone level value. Phone contact information for


Locations(1)

Centre Hospitalier Universitaire de la Guadeloupe

Pointe-à-Pitre, Guadeloupe, Guadeloupe

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07251036